Orange Book product · Generic (ANDA)
METHYLDOPATE HYDROCHLORIDE
METHYLDOPATE HYDROCHLORIDE
At a glance
Jan 02, 1987
Approved
Generic (ANDA)
Application
Not listed
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Jan 02, 1987
40 yr ago
Today
Pharmaceutical detail
Active ingredient
METHYLDOPATE HYDROCHLORIDE
Strength
50MG/ML
Dosage form
INJECTABLE
Route
INJECTION
TE code
Not listed
Application
ANDA 070841
Product number
001
Marketing status
DISCN
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of METHYLDOPATE HYDROCHLORIDE
- —ALDOMETBrand (NDA)
NDA 013401 · MERCK
- 1991METHYLDOPATE HYDROCHLORIDEGeneric (ANDA)
ANDA 072974 · TEVA PARENTERAL
- 1987METHYLDOPATE HYDROCHLORIDEGeneric (ANDA)
ANDA 071812 · MARSAM PHARMS LLC
- 1987METHYLDOPATE HYDROCHLORIDEGeneric (ANDA)
ANDA 071279 · AM REGENT
- 1987METHYLDOPATE HYDROCHLORIDEGeneric (ANDA)
ANDA 070691 · HOSPIRA
- 1987METHYLDOPATE HYDROCHLORIDEGeneric (ANDA)
ANDA 070849 · HOSPIRA
- 1987METHYLDOPATE HYDROCHLORIDEGeneric (ANDA)
ANDA 070698 · HOSPIRA
- 1987METHYLDOPATE HYDROCHLORIDEGeneric (ANDA)
ANDA 070699 · HOSPIRA
- 1986METHYLDOPATE HYDROCHLORIDEGeneric (ANDA)
ANDA 070291 · BAXTER HLTHCARE
- 1986METHYLDOPATE HYDROCHLORIDEGeneric (ANDA)
ANDA 070652 · ABRAXIS PHARM
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
